Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Cavallone

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthErika Cavallone, Miriam T Ashford, Joseph Eichenbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsJoseph Eichenbaum, Miriam T Ashford, Chengshi Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation StudyKhoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 22, 2021
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Bita Fakhri, Weiyun Z Ai, et al.
Journal of Medical Internet Research|August 11, 2025
Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort StudyJae Myeong Kang, Manchumad Manjavong, Adam Diaz, et al.
Alzheimer'S Research & Therapy|January 8, 2025
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health RegistryJae Myeong Kang, Manchumad Manjavong, Chengshi Jin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthErika Cavallone, Miriam T Ashford, Joseph Eichenbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsJoseph Eichenbaum, Miriam T Ashford, Chengshi Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation StudyKhoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 22, 2021
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Bita Fakhri, Weiyun Z Ai, et al.
Journal of Medical Internet Research|August 11, 2025
Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort StudyJae Myeong Kang, Manchumad Manjavong, Adam Diaz, et al.
Alzheimer'S Research & Therapy|January 8, 2025
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health RegistryJae Myeong Kang, Manchumad Manjavong, Chengshi Jin, et al.
Pageof 1